21例新型冠状病毒肺炎患者药物治疗方案的回顾性分析

Retrospective Analysis of 21 COVID-19 Patients’ Therapeutic Regimen

摘要: 目的对21例治愈出院的新型冠状病毒肺炎患者的治疗方案进行评价分析，为后续病例的诊治提供参考。方法回顾性分析2020年2—4月治愈出院的新型冠状病毒肺炎患者的病例资料及药物治疗方案。结果所有确诊患者均有流行病学史，以普通型(90.5%)为主，依据诊疗方案给予抗病毒治疗和其他支持治疗，疗效和安全性良好，所有患者均治愈出院。结论临床药师应追踪新型冠状病毒肺炎研究进展，参与方案制定，针对患者个体化情况，提出药学建议，保证患者的安全合理用药。

Abstract: OBJECTIVE To evaluate the medical treatment of 21 COVID-19 discharged patients, and provide reference for the diagnosis and treatment of follow-up cases.METHODS Retrospectively analyzed the case data and medical treatment of COVID-19 patients who were discharged from February 2020 to April 2020.RESULTS All the patients had an epidemiological history, the mainly type was common(90.5%). Antiviral treatment and other supportive treatment were given, with good efficacy and safety. All patients were cured and discharged.CONCLUSION Clinical pharmacists should actively participate in the formulation of therapeutic regimen for COVID-19. The pharmaceutical suggestions are put forward to ensure the rational use of drugs and safety.